About
BPI Labs manufactures sterile injectable pharmaceuticals for hospitals, clinics, and specialty care settings. They produce a broad portfolio of generic medications using robotic aseptic filling and advanced testing to meet critical patient needs. Their FDA-approved, cGMP-certified facility ensures high-purity products with rigorous quality controls.
As a 503B outsourcing facility and subsidiary of Belcher Pharmaceuticals, BPI Labs addresses drug shortages through precise production. They employ cutting-edge isolation technology and in-house analytical testing for reliable supply. This measured approach supports healthcare providers with consistent, compliant injectables.
BPI Labs focuses on innovation in sterile manufacturing to advance patient care. Their commitment to regulatory excellence delivers optimized medications nationwide. They prioritize quality in every formulation to sustain healthcare delivery.
Longevity Contribution
- Robotic ISO5 aseptic filling for superior sterility over manual laminar flow methods.
- Fully automated high-speed AI visual inspection for unmatched quality control.
- In-house analytical and microbiological testing to ensure high-purity injectables.
- 503B outsourcing facility status enabling bulk compounding for hospitals and clinics.